Ipamorelin + MOD GRF 1–29 Blend

Ipamorelin + MOD GRF 1–29 Blend: Ultra-Pure Research Peptide Combination – Verified Purity & Trusted Results

🔬 Precision-Formulated Growth Hormone Secretagogue Peptide Blend – ≥99% Purity Verified for Advanced Laboratory Research
📜 Scientifically Validated – Comprehensive Certificates of Analysis (COAs) & Rigorous HPLC Analytical Quality Assurance
🌍 Trusted by Leading Laboratories & Research Institutions Worldwide

Chemical Information:

Ipamorelin (Ipamorelin Acetate):

• Synonyms: Ipamorelin, Ipamorelin Acetate
• CAS Number: 170851-70-4
• Molecular Formula: C₃₈H₄₉N₉O₅
• Molecular Weight: Approximately 711.86 Da
• Purity: ≥99% Peptide-Grade (Validated by HPLC)

MOD GRF 1–29 (CJC-1295 without DAC):

• Synonyms: Modified GRF 1–29, CJC-1295 without DAC
• CAS Number: 863288-34-0
• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: Approximately 3367.9 Da
• Purity: ≥99% Peptide-Grade (Validated by HPLC)

Scientific Overview of the Peptide Blend:

The Ipamorelin + MOD GRF 1–29 Blend combines two scientifically distinguished peptides with complementary modes of action:

• Ipamorelin, a highly selective growth hormone secretagogue, interacts specifically with GHS-R receptors, stimulating growth hormone (GH) release with minimal effect on cortisol or prolactin.
• MOD GRF 1–29 (CJC-1295 without DAC), a modified analogue of Growth Hormone-Releasing Hormone (GHRH), effectively stimulates GH secretion through selective activation of GHRH receptors.

Combined, these peptides offer synergistic research opportunities for exploring growth hormone regulation, cellular receptor dynamics, and endocrine signalling pathways (Wikipedia: Ipamorelin).

Key Scientific References and Literature:

• Raun et al., European Journal of Endocrinology (1998) – Characterisation of Ipamorelin’s growth hormone-releasing specificity and receptor selectivity.
• Teichman et al., Clinical Endocrinology (2006) – Evaluation of MOD GRF 1–29’s receptor specificity, pharmacokinetics, and its GH secretagogue effects in vitro.
• Pentikäinen et al., Journal of Endocrinology (1999) – Investigation of biochemical interactions and molecular mechanisms modulated by Ipamorelin in laboratory models.

Precision Formulation & Quality Assurance:

✅ Equal Peptide Ratios: Accurately proportioned peptides ensure consistency and reproducibility in research outcomes.
✅ Comprehensive Quality Verification: Each batch undergoes rigorous HPLC and mass spectrometry analyses to confirm purity, composition, and stability.
✅ Optimised Stability: Meticulously selected peptide combinations ensure structural integrity and long-term stability for laboratory applications.

Why Choose Our Ipamorelin + MOD GRF 1–29 Blend?

✅ Advanced HPLC Analytical Verification – Ensuring ≥99% Purity for Accurate Experimental Results
✅ Certificates of Analysis (COAs) – [Instant QR Code Verification Available]
✅ Material Safety Data Sheet (MSDS) – Comprehensive Laboratory Safety & Compliance Documentation
✅ Manufactured in a UK Laboratory – Produced Under Stringent Quality Control Standards
✅ Rapid & Secure Express Delivery – Timely Dispatch & Secure Packaging to Preserve Stability
✅ Independent Third-Party Testing – Available Upon Request for Enhanced Transparency

For Research Use Only

Our Ipamorelin + MOD GRF 1–29 Blend is synthesised strictly for scientific research and laboratory studies. It is explicitly not intended or approved for human consumption or therapeutic use.

Advance your cutting-edge research confidently with our meticulously synthesised Ipamorelin + MOD GRF 1–29 Blend, ensuring precise, reproducible, and scientifically robust outcomes.